In Vitro Effect of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid Viruses
John H. Huffman,Robert W. Sidwell,Gyaneshwar P. Khare,Joseph T. Witkowski,Lois B. Allen,Roland K. Robins +5 more
TLDR
Parallel experiments indicated Virazole to have at least a comparable degree of activity, and it was also active against a wider variety of viruses than any of these known active materials.Abstract:
Virazole (1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a highly soluble new synthetic nucleoside having significant, reproducible activity against a broad spectrum of deoxyribonucleic acid and ribonucleic acid viruses in vitro. The drug inhibited viral cytopathogenic effects in monolayers of cells infected for 3 days with type 3 adeno, types 1 and 2 herpes, myxoma, cytomegalo, vaccinia, infectious bovine rhinotracheitis, types 1A, 2, 8, 13, and 56 rhino, types 1 and 3 parainfluenza, vesicular stomatitis, subacute sclerosing panencephalitis, Semliki Forest, Newcastle disease, and measles viruses. Hemagglutinin production by influenza A(2), influenza B, and type 1 parainfluenza viruses in chicken embryo cells was reduced by Virazole treatment. Recoverable intra- and extracellular virus titers were reduced by the drug in experiments with type 1 herpes, vaccinia, type 3 parainfluenza, and vesicular stomatitis viruses. Plaque formation by type 1 herpesvirus was also inhibited by exposure of the infected cells to Virazole. Pretreatment of cells with the compound, followed by its removal before addition of type 1 herpesvirus, severely lessened the antiviral activity; the compound was still moderately effective in reducing the viral effects on the cells when added as long as 22 hr after the virus. Parallel experiments, in which the antiviral activity of a number of known active drugs was compared, indicated Virazole to have at least a comparable degree of activity, and it was also active against a wider variety of viruses than any of these known active materials. The CCED(50) of Virazole to chicken embryo cells was approximately 1,000 mug/ml, although concentrations as low as 10 mug/ml caused slight (15%) inhibition in total cellular protein after 72 hr of incubation.read more
Citations
More filters
Journal ArticleDOI
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
Caroline B. Hall,John T. McBride,Edward E. Walsh,D M Bell,Christine L. Gala,Stephen W. Hildreth,Ten Eyck Lg,William J. Hall +7 more
TL;DR: By the end of treatment, infants receiving ribavirin had significantly greater improvement in their overall score for severity of illness, in lower-respiratory-tract signs, and in arterial oxygen saturation.
Journal ArticleDOI
Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro
Giovanni Migliaccio,Joanne E. Tomassini,Steven S. Carroll,Licia Tomei,Sergio Altamura,Balkrishen Bhat,Linda Bartholomew,Michele Bosserman,Alessandra Ceccacci,Lawrence F. Colwell,Riccardo Cortese,Raffaele De Francesco,Anne B. Eldrup,Krista Getty,Xiaoli S. Hou,Robert L. Lafemina,Steven W. Ludmerer,Malcolm MacCoss,Daniel R. McMasters,Mark Stahlhut,David B. Olsen,Daria J. Hazuda,Osvaldo A. Flores +22 more
TL;DR: 2′-C-methyl-substituted ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication and the combination of these agents with interferon-α results in synergistic inhibition of HCv genome replication in cell culture.
Journal ArticleDOI
A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
David W. Smith,Lorry R. Frankel,Larry H. Mathers,Allen T.S. Tang,Ronald L. Ariagno,Charles G. Prober +5 more
TL;DR: In infants who require mechanical ventilation because of severe respiratory syncytial virus infection, treatment with aerosolized ribavirin decreases the duration of mechanical ventilation, oxygen treatment, and the hospital stay.
Journal ArticleDOI
Plaque inhibition assay for drug susceptibility testing of influenza viruses.
F G Hayden,K M Cote,R G Douglas +2 more
TL;DR: This assay proved to be a reliable, rapid method of determining 50% inhibitory concentrations that correlated well with clinically achievable drug levels and the results of clinical trials.
Journal ArticleDOI
A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties
David B. Olsen,Anne B. Eldrup,Linda Bartholomew,Balkrishen Bhat,Michele Bosserman,Alessandra Ceccacci,Lawrence F. Colwell,John F. Fay,Osvaldo A. Flores,Krista Getty,Jay A. Grobler,Robert L. Lafemina,Eric J. Markel,Giovanni Migliaccio,Marija Prhavc,Mark Stahlhut,Joanne E. Tomassini,Malcolm MacCoss,Daria J. Hazuda,Steven S. Carroll +19 more
TL;DR: 7-deaza-2′-C-methyl-adenosine is an attractive candidate for further investigation as a potential treatment for HCV infection and displays promising in vivo pharmacokinetics in three animal species, as well as an acute oral lethal dose in excess of 2,000 mg/kg of body weight in mice.
References
More filters
Journal ArticleDOI
A simple method of estimating fifty per cent endpoints
Lowell J. Reed,H. Muench +1 more
Journal ArticleDOI
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.
Robert W. Sidwell,John H. Huffman,Gyaneshwar P. Khare,Lois B. Allen,Joseph T. Witkowski,Roland K. Robins +5 more
TL;DR: Virazole is a synthetic nucleoside active in tissue culture against at least 16 DNA and RNA viruses and applied topically, it inhibits herpetic keratitis in rabbits and tail lesions induced by herpes, vaccinia, and vesicular stomatitis viruses in mice.
Journal ArticleDOI
Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau).
Vance I. Oyama,Harry Eagle +1 more
TL;DR: An analytical method for the measurement of cell growth in tissue culture is described, based on the Lowry method forthe determination of protein, and employing a phenol reagent (Folin-Ciocalteau) for color development.
Journal ArticleDOI
Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides
Journal ArticleDOI
Use of Disposable Micro Tissue Culture Plates for Antiviral and Interferon Induction Studies
TL;DR: A reproducible test system requiring small amounts of test compound was developed for evaluating antiviral and interferon-inducing activity and known active compounds evaluated in this microplate system had activity similar to that seen in macro in vitro systems.